XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2023
Dec. 31, 2022
[1]
CURRENT ASSETS    
Cash and cash equivalents $ 260,633,625 $ 214,754,638
Restricted Cash 0 4,000,000
Short-term investments 17,464,830 23,007,385
Accounts receivable, net 351,142,147 276,493,752
Inventories 395,452,780 404,360,270
Prepaid expenses and other 30,758,445 26,036,331
Total current assets 1,055,451,827 948,652,376
PLANT AND EQUIPMENT—NET 606,180,738 550,033,036
OTHER ASSETS    
Goodwill 313,157,393 313,807,494
Long-term investments 272,615,535 202,331,983
Intangible assets, net 204,885,910 219,360,910
Deferred tax asset 36,513,490 25,528,700
Patents and other assets, net 69,513,945 67,515,425
Total other assets 896,686,273 828,544,512
Total assets 2,558,318,838 2,327,229,924
CURRENT LIABILITIES    
Accounts payable 171,359,850 151,740,046
Accrued liabilities 103,045,653 98,812,706
Total current liabilities 274,405,503 250,552,752
OTHER NON-CURRENT LIABILITIES 15,459,528 10,884,351
Total liabilities 289,865,031 261,437,103
SHAREHOLDERS’ INVESTMENT    
Common stock 13,995,548 14,050,160
Additional paid-in capital 961,199,149 917,499,323
Retained earnings 1,306,931,850 1,148,386,272
Accumulated other comprehensive loss (13,672,740) (14,142,934)
Total shareholders’ investment 2,268,453,807 2,065,792,821
Total liabilities and shareholders’ investment $ 2,558,318,838 $ 2,327,229,924
[1] The condensed consolidated balance sheet at December 31, 2022 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.